RNU6-1023P

Across TCGA pan-cancer cohorts, RNU6-1023P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-1023P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU6-1023P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1023P expression acts as an unfavorable survival marker.

OV, COAD, and BLCA are the cancer types where RNU6-1023P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	All	0.150	0.542	<.001	144	view →
COAD	OS	Tertile	III,IV	0.045	0.783	<.001	72	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
STAD	OS	Tertile	II,III,IV	0.454	0.725	.023	36	view →
HNSC	DFS	Tertile	III,IV	0.050	0.611	<.001	36	view →
SKCM	OS	Tertile	III,IV	0.232	0.721	.010	36	view →
SARC	OS	Tertile	All	0.429	0.865	.014	12	view →
PAAD	DFS	Tertile	All	0.173	0.485	.030	9	view →
LUSC	DFS	Tertile	All	0.211	0.646	.022	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-1023P–OV (DFS)

Open the OV breakdown →